Clinical Trials
5 trialsNCT04699630 2026-05-22
A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT05865990 2026-05-04
TUXEDO-3
MedSIR
Phase 2 Completed
NCT04965766 2025-12-23
ICARUS BREAST
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Recruiting
NCT06383884 2025-12-15
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Samsung Medical Center
Phase 2 Recruiting
NCT05620914 2025-06-15
PARAMETer
Duke University
Phase 2 Withdrawn